Clinical Trial

Comparison of Two Surgical Techniques for Treatment of Type III Obesity (BMI 40-50 kg/m2): Single Anastomosis Duodenoileal Bypass With Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.

Study acronym: BYPSADIS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Roux-en-Y gastric bypass (RY-GBP) is one of the surgical techniques most widely used for the treatment of obesity. Long series of operated patients published in the literature have demonstrated its safety and efficacy. It consists on the reduction of the size of the stomach and joining it (anastomosis) with the small bowel to reduce the absorption of calories. Single anastomosis duodenoileal with sleeve gastrectomy is an increasingly used surgical technique that is a simplification of the duodenal switch. It consists on the reduction of the stomach to a tube (sleeve gastrectomy) and an anastomosis between the duodenum and the small bowel. It has been demonstrated as a effective technique and it is supported by the international scientific societies. There are no data that indicate a superiority of one technique over the other. The objective of this study is to analyze if there are differences between the two techniques in terms of postoperative weight control and gastroesophageal reflux at short, medium and long term.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-22.
Status change: Not Yet Recruiting → Recruiting 2025-04-30
Trial Details
NCT Number NCT06789965
Lead Sponsor Hospital Clinic of Barcelona
Conditions Obesity
Enrollment 450 participants
Start Date 2025-02-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2030-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-04